Patents by Inventor Antonia Vlahou

Antonia Vlahou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bladder cancer biomarker proteins
    Patent number: 11536724
    Abstract: The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: December 27, 2022
    Assignees: POLYQUANT GMBH, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS, LUXEMBOURG INSTITUTE OF HEALTH, INSTITUT CURIE, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO
    Inventors: Jerome Garin, Christophe Masselon, Antonia Vlahou, Manousos Makrydakis, Ieronimos Zoidakis, Bruno Domon, Elodie Duriez, Aurelie Kamoun, Francois Radvanyi, Yves Allory, Nuria Malats Riera, Mirari Marquez Cid, Magali Court
  • BLADDER CANCER BIOMARKER PROTEINS
    Publication number: 20180372754
    Abstract: The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Type: Application
    Filed: December 23, 2016
    Publication date: December 27, 2018
    Inventors: Jerome GARIN, Christophe MASSELON, Antonia VLAHOU, Manousos MAKRYDAKIS, Ieronimos ZOIDAKIS, Bruno DOMON, Elodie DURIEZ, Aurelie KAMOUN, Francois RADVANYI, Yves ALLORY, Nuria MALATS RIERA, Mirari MARQUEZ CID, Magali COURT
  • Biomarkers for Bladder Cancer
    Publication number: 20080026410
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying bladder cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as bladder cancer or non-bladder cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: July 20, 2005
    Publication date: January 31, 2008
    Inventor: Antonia Vlahou
  • Biomarkers of transitional cell carcinoma of the bladder
    Publication number: 20040043436
    Abstract: The invention provides markers, methods and kits that can be used as an aid for diagnosis of transitional cell carcinoma of the bladder (TCC) using markers that are differentially present in the samples of TCC patients and a control (e.g., subjects in whom TCC is undetectable).
    Type: Application
    Filed: August 21, 2003
    Publication date: March 4, 2004
    Inventors: Antonia Vlahou, George L Wright